These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17591142)

  • 1. The use of activated protein C in severe Plasmodium falciparum malaria.
    Rankin LG; Austin DL
    Anaesth Intensive Care; 2007 Jun; 35(3):428-32. PubMed ID: 17591142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of drotrecogin alfa in severe falciparum malaria.
    Robak O; Bojic A; Locker GJ; Laczika K; Ramharter M; Staudinger T
    Anaesth Intensive Care; 2010 Jul; 38(4):751-4. PubMed ID: 20715743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drotrecogin alfa (activated) in severe falciparum malaria.
    Kendrick BJ; Gray AG; Pickworth A; Watters MP
    Anaesthesia; 2006 Sep; 61(9):899-902. PubMed ID: 16922759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activated protein C in severe Plasmodium falciparum malaria].
    Soto-Blanco JM; Yuste-Osorio E; Olivencia-Peña L; Matarán-Robles E
    Med Clin (Barc); 2011 May; 136(14):648-9. PubMed ID: 21051059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of severe sepsis and multiple organ failure with activated protein C].
    Strøm JJ
    Ugeskr Laeger; 2004 Mar; 166(11):995. PubMed ID: 15049233
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is there a place for activated protein C (Xigris) in the treatment of severe imported malaria in the adult?].
    Nau A; Peytel E; Petrognani R
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1085-6. PubMed ID: 17005364
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in treating patients with severe sepsis. Role of drotrecogin alfa (activated).
    Kleinpell R
    Crit Care Nurse; 2003 Jun; 23(3):16-29; quiz 67-8. PubMed ID: 12830777
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe sepsis due to severe falciparum malaria and leptospirosis co-infection treated with activated protein C.
    Srinivas R; Agarwal R; Gupta D
    Malar J; 2007 Apr; 6():42. PubMed ID: 17428347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xigris--activated protein C].
    Tønnesen EK
    Ugeskr Laeger; 2004 Mar; 166(11):1002-4. PubMed ID: 15049235
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum levels of adhesion molecules and thrombomodulin as indicators of vascular injury in severe Plasmodium falciparum malaria.
    Boehme MW; Werle E; Kommerell B; Raeth U
    Clin Investig; 1994 Aug; 72(8):598-603. PubMed ID: 7819716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drotrecogin alfa in tropical infections and refractory multi-organ failure.
    Kapadia F; Shirwadkar C
    Intensive Care Med; 2006 Aug; 32(8):1281-2. PubMed ID: 16741686
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical approach to the identification of patients suffering from severe sepsis with several organ failures for the administration of drotrecogin alfa (activated): from the PROWESS study to clinical practice].
    Dhainaut JF; Payen DM; Bernardin G; Gérard JL; Martin C; Perrotin D; Regnier B
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():53-64. PubMed ID: 15359946
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activated protein C--recent addition to therapy of sepsis].
    Gårdlund B; Sjölin J
    Lakartidningen; 2003 Jun; 100(26-27):2292-6. PubMed ID: 12872375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new drug which saves lives. Sepsis: chaos in the body--recent aspects of pathophysiology and therapy].
    Haas I
    Krankenpfl J; 2002; 40(10-12):310-4. PubMed ID: 12600015
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis].
    Heslet L; Nielsen JD; Schierbeck J; Andersen JS
    Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human activated protein C (Xigris).
    Levi M; De Jonge E; van der Poll T
    Int J Clin Pract; 2002 Sep; 56(7):542-5. PubMed ID: 12296618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles for hemostatic dysfunction in malaria pathogenesis.
    O'Sullivan JM; Preston RJ; O'Regan N; O'Donnell JS
    Blood; 2016 May; 127(19):2281-8. PubMed ID: 26851291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid Pulse Therapy May Mitigate Prolonged Neurological Manifestations after Eradication of Severe Plasmodium falciparum Parasitemia.
    Hasegawa C; Inagaki A; Yamada G; Morita K; Kitamura I; Ariyoshi K
    Intern Med; 2016; 55(22):3393-3398. PubMed ID: 27853090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe sepsis.
    Bernard G
    Am J Surg; 2002 Dec; 184(6A Suppl):S3-4. PubMed ID: 12521611
    [No Abstract]   [Full Text] [Related]  

  • 20. Drotrecogin Alfa (Activated): From Bench to Practical Use at the Bedside. Proceedings of meetings of the Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Clinical Evaluation Committee.
    Am J Surg; 2002 Dec; 184(6A Suppl):1S-49S. PubMed ID: 12521610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.